EKF Diagnostics (LON:EKF) Stock Price Passes Above 200-Day Moving Average – Should You Sell?

EKF Diagnostics Holdings plc (LON:EKF) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 25.29 and traded as high as GBX 27.90. EKF Diagnostics shares last traded at GBX 26.60, with a volume of 180,510 shares changing hands.

Analyst Ratings Changes

Separately, Stifel Nicolaus reiterated a “buy” rating and set a GBX 35 price objective on shares of EKF Diagnostics in a report on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of GBX 35.

EKF Diagnostics Stock Performance

The firm has a fifty day moving average price of GBX 25.02 and a 200 day moving average price of GBX 25.29. The company has a debt-to-equity ratio of 2.01, a quick ratio of 1.77 and a current ratio of 4.16. The stock has a market cap of £114.53 million, a PE ratio of 56.60 and a beta of 0.53.

EKF Diagnostics (LON:EKF) last issued its earnings results on Tuesday, March 24th. The company reported GBX 0.47 earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%. Research analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.